Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of The Effect of Hepatic Impairment on The Pharmacokinetics of Aleglitazar
This study has been completed.
Study NCT01197911   Information provided by Hoffmann-La Roche

First Received on September 8, 2010.   Last Updated on August 26, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial